Aleksandra Markovets

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip et al. · Nature Medicine · 2015 · 1.5K citations · Full text

Medicine, Molecular Biology, Oncology +11

VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

Zhongwu Lai, Aleksandra Markovets, Miika Ahdesmäki et al. · Nucleic Acids Research · 2016 · 1.1K citations · Full text

Life Sciences, Genetics, Oncology +17

Osimertinib As First-Line Treatment of <i>EGFR</i> Mutation–Positive Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, James Chih‐Hsin Yang, Chee Khoon Lee et al. · Journal of Clinical Oncology · 2017 · 536 citations

Medicine, Oncology, Pharmacology +14

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

Suresh S. Ramalingam, Yi Cheng, C. Zhou et al. · Annals of Oncology · 2018 · 355 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Catherine A. Eberlein, Daniel Stetson, Aleksandra Markovets et al. · Cancer Research · 2015 · 300 citations · Full text

Medicine, Oncology, Pharmacology +17